DR AMIT M.B.B.S, MD Nuclear Medicine and PET Imaging

adpfob@r.postjobfree.com +91-701*-***-*** / +44-773*******

Experienced Nuclear Medicine Physicians with 8+ years of experience trained at national and international center of excellence with interest in PET and radionuclide therapies for better outcomes and value based healthcare patient management care. WORK EXPERIENCE

• Clinical Fellow- Royal Liverpool University NHS Hospital Trust, Liverpool-UK March 2020 to Present

• Fellow (Nuclear Oncology )-Royal Liverpool University Hospital, Liverpool-UK Sept to Nov 2018

Gained experience in 18F FDG Oncology, 68Ga PSMA and 68Ga Octreotide PET CT Imaging, NET PRRT Therapy

Research Work-PET Infection Imaging in Cardiac and Orthopaedic Implants, Ra223 Bone pain palliation therapy

• Fellow (Theranostics and PET/CT )- Peter Mac Callum Cancer Centre-Australia 2015

Gained experience with 18F FDG & non FDG tracers as 68Ga Octreotide, 68Ga PET/CT V/Q, I-124, 18F-FLT

Research Work- 68Ga PSMA mCRPC and PRRT-NET Therapy

• Consultant (Nuclear Medicine)- Regional Cancer Centre, Shimla -Himachal 2012-2020

ACADEMIC QUALIFICATION

• MD (Nuclear Medicine) - Post Graduate Institute of Medical Education & Research

(PGIMER),Chandigarh 2009-2012

• Radiation Safety officer(II) Certification-Bhabha Atomic Research Centre, Mumbai. 2012

RESEARCH ACHIEVEMENTS

• 2016- Research work accepted for top 3 dedicated e-poster walk in PET in Oncology Category at Congress of European Association of Nuclear Medicine

(EANM)

• 2014- Recommended for International Travel Grants, Dept. Of Science & Technology (DST), Govt. of India.

• 2012- Society of Nuclear Medicine and Molecular Imaging (SNMMI), USA travel award for research presentations- One of 20 candidates chosen internationally

• 2012- Top 10 candidate for poster award in General Nuclear Medicine Research Category at Society of Nuclear Medicine and Molecular Imaging (SNMMI) USA

• 2012- Received International Travel Grants from Indian Council if Medical Research (ICMR), Govt. of India

PUBLICATION LIST

• Tubercular spondylitis: A rare complication of BCGosis masquerading as metastases on 18F-PSMA-1007 PET/CT

• F18 PSMA 1007 PET/CT experience with equivocal lesions in prostate cancer: Has the time come for PSMA-RADS?

• Factors influencing outcome post Radium 223 dichloride in castrate resistant prostate cancer- A review of some real world challenges.

• Comparison of 68Ga PSMA PET/CT with multiparametric(mp) MRI in prostate cancer for staging and restaging and its impact on patient management in the real world scenario

• Role of 18F-flurodeoxyglucose in orthopaedic implant-related infection: review of literature and experience.

• Role of 18F-FDG PET/CT in infection of cardiovascular implantable electronic devices: review of the literature and initial experience.

• Challenges using PET-CT for international multi-centre coordinated research projects in developing countries.

• F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Rare Case of Recurrent Malignant Mixed Mullerian Tumor.

• Can 3'-deoxy-3'-18F-fluorothymidine or 2'-deoxy-2'-18F-fluoro-d-glucose PET/CT better assess response after 3-weeks treatment by epidermal growth factor receptor kinase inhibitor, in nonsmall lung cancer patients? Preliminary results.

• Role of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence in patients with cervical cancer

• Renal cell carcinoma presenting as isolated deltoid muscle metastasis 12 years after radical nephrectomy detected on F-18 FDG PET/CT.

• Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.

• (99m)Tc-pertechnetate scintigraphy and endoscopy in assessment of caustic induced gastric mucosal injury.

• Is 68Ga-DOTATATE the answer in lung carcinoid? : Case report and review literature.

• Hybrid Single Photon Emission Computed Tomography/Computed Tomography Sulphur Colloid Scintigraphy in Focal Nodular Hyperplasia.

• Factors Predicting Treatment Failure in Patients Treated with Iodine-131 for Grave’s Disease.

• Methylene diphosphonate uptake in a case of vertebral hemangioma: demonstration with hybrid SPECT/CT.

ACADEMIC LEADERSHIP

• Reviewer for British Nuclear Medicine Society (BNMS) official journal- Nuclear Medicine Communication

• Reviewer for British Medical Journal(BMJ) Case Reports

• Educational Book Expert Panel Member for American Society of Clinical Oncology

(ASCO)

Contact this candidate